Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Nuvance advances to phase II clinical trials for long-term control of asthma

March 3, 1999

HFA-134a-BDP controls asthma at half the dose of traditional inhalers

March 3, 1999

Licensing opportunity from BTG: xanthine oxidase inhibitors for treatment of ARDS

March 3, 1999

PDE4 inhibitors claimed by Byk Gulden for airways disorders

March 3, 1999

PPL's initial results of AAT trial in cystic fibrosis

March 1, 1999

Licensing opportunity from BTG: antiasthmatic compound with a novel mechanism of action

March 1, 1999

Clinical trial shows HP-3 effective in COPD

March 1, 1999

Taiwan university researchers present new ATP-sensitive potassium channel opener

Feb. 25, 1999

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

Purinoceptor antagonists claimed by Astra, useful for inflammatory diseases

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...